| Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses J Li, Y Wang, K Solanki, R Atre, M Lavrijsen, Q Pan, MS Baig, P Li Antiviral Research 211, 105555, 2023 | 15 | 2023 |
| Light intensity affects tolerance of pyrene in Chlorella vulgaris and Scenedesmus acutus RS Tomar, R Atre, D Sharma, P Rai-kalal, A Jajoo Photosynthetica 61 (SPECIAL ISSUE 2023/1), 168-176, 2023 | 6 | 2023 |
| The indispensability of macrophage adaptor proteins in chronic inflammatory diseases R Atre, R Sharma, G Vadim, K Solanki, K Wadhonkar, N Singh, P Patidar, ... International Immunopharmacology 119, 110176, 2023 | 2 | 2023 |
| An improved mouse model of sepsis based on intraperitoneal injections of the enriched culture of cecum slurry R Atre, R Sharma, AG Obukhov, U Saqib, S Umar, GN Darwhekar, ... Life Sciences 345, 122584, 2024 | | 2024 |
| Adaptor molecules mediate negative regulation of macrophage inflammatory pathways: a closer look MS Baig, S Barmpoutsi, S Bharti, A Weigert, N Hirani, R Atre, R Khabiya, ... Frontiers in Immunology 15, 1355012, 2024 | | 2024 |
| Targeting signalling pathways in inflammatory diseases MS Baig, TLM Thurston, R Sharma, R Atre, U Saqib, R Khabiya, S Bharti, ... Frontiers in Immunology 14, 1241440, 2023 | | 2023 |
| Small Molecule Inhibitors Targeting Endothelial IL-1β Receptor (IL-1R1): A Novel Approach to Atherosclerosis Therapy BMS Solanki K1#, Atre R1#, Sharma R1, Bezsonov E2,3,4 Austin Journal of Pharmacology and Therapeutics 11 (Issue 1 - 2023), 11(1): 1170, 2023 | | 2023 |
| Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy K Solanki, A Kumar, MS Khan, S Karthikeyan, R Atre, KYJ Zhang, ... Current Research in Structural Biology 6, 100110, 2023 | | 2023 |
| Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses K Solanki, R Atre, MS Baig Elsevier BV, 2023 | | 2023 |
Anjana JajooSchool of Life scienceVerified email at dauniv.ac.in
